Lemonade, Inc. LMND

44.93 (0.35) (0.77%) as of 25 Sep
Market cap
$3.5B
P/E
0.0×
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.49
Total sells 37.73
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — 1 — — — — — —
Sell — 3 8 4 — 3 — — 3 2 1 3
Insider Ownership 9.84%

Capital & Financial Ratios

Market Cap 3,530.00
Revenue 975.00
Net Income (138.40)
Free Cash Flow 8.10
Net Debt (173.90)
Current Ratio 0.81
Debt/Equity 0.41
P/E ratio 0.00
P/S ratio 3.55
P/B ratio 6.92
Past 5Y EPS Growth (8.22%)
This Y EPS Growth 17.40%
Next Y EPS Growth 42.27%
Next 5Y EPS Growth 36.59%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2019 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 272 386 397 380
Receivables 360 472 556 623
Inventory — — — —
Other — — — —
632 857 952 1,003
2023 2024 2025 Q'26
Payables 681 847 943 1,026
ST’ Debt 15 83 158 206
Other — — — —
696 930 1,101 1,233
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — 50.87% 42.19%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — (0.28%) (14.93%)

Revenue

Mar Jun Sep Dec Year
’26 258 294 — — —
’25 151 164 195 228 738
’24 119 122 137 149 527
’23 95 105 115 116 430
’22 44 50 74 88 257
’21 24 28 36 41 128
’20 26 30 18 21 94
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (1) (3) — — —
’25 (47) 6 5 21 (16)
’24 (30) (12) 16 14 (11)
’23 (46) (50) (6) (16) (119)
’22 (39) (40) (55) (29) (163)
’21 (40) (16) (38) (50) (145)
’20 (19) (16) (36) (21) (92)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (4) (8) — — —
’25 (49) 3 3 18 (26)
’24 (32) (13) 14 11 (21)
’23 (49) (52) (8) (18) (128)
’22 (42) (42) (58) (31) (173)
’21 (42) (19) (41) (52) (154)
’20 (20) (17) (37) (22) (96)
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (0.47) (0.56) — — —
’25 (0.86) (0.60) (0.51) (0.29) (2.24)
’24 (0.67) (0.81) (0.95) (0.42) (2.85)
’23 (0.95) (0.97) (0.88) (0.61) (3.40)
’22 (1.21) (1.10) (1.37) (0.93) (4.59)
’21 (0.81) (0.90) (1.08) (1.14) (3.94)
’20 (3.16) (1.77) (0.57) (0.60) (3.63)
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

2.8
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — — 44.11 39.20 12.82 10.27 14.03 24.31

Analyst estimates 2026–2028

Powerpack
Low Price
— — — — 137.30 188.30 44.50 24.81 53.85 85.20
High Price
— — — 329 567 1,119 1,367 1,258 1,235 1,282
Employees
— 0 0 0 0 0 0 0 0 1
Revenue/Emp
— 2 23 67 94 128 257 430 527 738
Revenue
— 0.00% 32.44% 31.95% 42.06% 44.00% 34.83% 34.76% 47.39% 52.97%
Gross Margin
— (28) (53) (108) (121) (234) (295) (230) (204) (161)
EBT
— (1,166.67%) (233.78%) (160.33%) (127.97%) (181.93%) (114.84%) (53.47%) (38.73%) (21.81%)
EBT Margin
— (28) (53) (108) (122) (241) (298) (237) (202) (165)
Net Income
— — 0 0 1 0 19 17 14 9
Depreciation
— 0.04 2.06 6.05 2.80 2.10 3.95 6.17 7.41 9.98
Revenue/Sh
— (0.50) (4.84) (9.75) (3.63) (3.94) (4.59) (3.40) (2.85) (2.24)
Earnings/Sh
— (0.34) (3.73) (7.02) (2.72) (2.36) (2.51) (1.71) (0.16) (0.22)
Cash Flow/Sh
— 0.00 (0.06) (0.24) (0.13) (0.15) (0.16) (0.13) (0.13) (0.13)
Capex/Sh
— (0.34) (3.80) (7.26) (2.86) (2.52) (2.67) (1.84) (0.29) (0.35)
Free CF/Sh
— 0.57 0.00 26.76 16.07 16.14 13.35 10.18 8.36 7.22
Book Value/Sh
— 57 11 11 34 61 65 70 71 74
Shares
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PE Ratio
— 9.28 9.28 9.28 43.67 20.08 3.47 2.76 4.95 7.13
PS Ratio
— 0.00 0.00 0.00 7.62 2.61 1.03 1.67 4.39 9.86
PB Ratio
— 6.37 6.37 6.37 37.62 17.97 2.36 2.16 4.37 6.81
EV/Sales
— (7.18) (7.18) (7.18) (36.95) (14.98) (3.49) (7.25) (110.71) (194.00)
EV/FCF
— (19) (41) (78) (92) (145) (163) (119) (11) (16)
Op' Cash Flow
— 0 (1) (3) (4) (9) (10) (9) (9) (9)
Capex
— (19) (41) (81) (96) (154) (173) (128) (21) (26)
FCF
— — — 248 500 126 20 (64) (73) (148)
Working Cap'
— — — — — 22 26 15 83 158
Total Debt
— — — (270) (571) (271) (286) (257) (302) (239)
Net Debt
— 32 0 298 541 988 867 709 593 534
Sh' Equity
— (30.88%) (258.05%) (52.38%) (19.68%) (20.63%) (18.61%) (14.25%) (11.61%) (8.77%)
ROA
— 0.00% 0.00% (246.12%) 0.00% (20.35%) (31.75%) (31.75%) (43.78%) (34.10%)
ROIC
— 52.52% 98.88% 82.98% (68.23%) (31.56%) (32.11%) (30.07%) (31.05%) (29.37%)
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Lemonade, Inc. (LMND) key facts

  • Lemonade, Inc. (LMND) is an Insurance Property & Casualty company in the Financial sector, listed on the New York Stock Exchange.
  • Lemonade, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $737.9 million, up 40.2% from fiscal 2024.
  • Lemonade, Inc. reported a net loss of $165.5 million, or a loss of $2.24 per share, for fiscal 2025.
  • As of September 25, 2026, LMND traded at $44.93, a market capitalization of $3.5 billion.
  • Trailing earnings are negative, so a P/E ratio is not meaningful; the stock trades at 3.5× sales.
  • Return on equity was −29.4% and debt-to-equity 0.41.

Source: company filings (standardised) and stockrow calculations.

Lemonade, Inc. (LMND) Latest News

News by impact score

Fine-tune

25 Sep

3

Lemonade's shares have risen sharply, raising questions about whether the current market value aligns with sales. The stock trades at about 3.6x price-to-sales, well above insurance peers (~1.1x) and a tailored fair value, suggesting the valuation may be stretched. A Kentucky pet-insurance launch broadens Lemonade's U.S. footprint and could lift future premium volume and cross-selling optionality. Yet investors face execution risk if momentum or unit economics falter, and regulatory concerns (GDPR, CCPA) could pressure margins. Analysts split: bulls emphasize AI-driven underwriting and rapid adoption; bears highlight growth and data-privacy risks that could cap upside. The piece frames Lemonade against valuation benchmarks, emphasizing the need to see sustained revenue growth and margin improvements to justify current levels. Kentucky pet-insurance expansion adds optionality and potential revenue growth, but current P/S valuation appears stretched relative to peers and growth risk.

3

StockStory identifies Lemonade (LMND) as one of two stocks to sell in a weekly roundup, even as Wall Street remains bullish on other names. LMND sits at about $45.38 with a consensus target of $59.22 (roughly 30% implied return) and a 7.1x forward price-to-book. Yet the article flags weak profitability and balance-sheet deterioration: five-year earnings per share growth of 8% lags revenue growth, book value per share declines of about 18% per year, and a negative return on equity. Credit quality challenges and limited ability to self-fund growth further temper upside. The piece contrasts LMND with Celsius as the stock to watch and points readers to a free research report. Overall, LMND’s valuation is seen as too optimistic given fundamental headwinds. Flagged for weak profitability, declining book value, and negative ROE despite a bullish price target, potentially dampening sentiment.

3

Berkshire Hathaway remains a stable cash‑flow machine with a vast, diversified footprint in energy, transport, and consumer brands. 2025 revenue around $371.4 billion, net income about $67.0 billion, net margin ~18%; debt‑to‑equity ~0.2x; free cash flow roughly $25.0 billion. Lemonade operates as a digital‑first insurer using AI for pricing and claims, serving 3.3M+ customers by late 2026; 2025 revenue ~$737.9 million (+40% YoY), net loss about $165.5 million, net margin ~ -22.4%; current ratio ~1.5x; debt‑to‑equity ~0.3x; negative free cash flow ~ $25.9 million. Valuation: Berkshire trades around 23x forward earnings and 3x sales; Lemonade about 4.9x P/S but remains loss‑making. Risks: Berkshire faces macro and catastrophe exposure and leadership succession; Lemonade faces AI pricing risk, data biases, reinsurance reliance, and fierce competition. Conclusion: Berkshire’s scale makes it hard for Lemonade to topple; investors may wait for sustained profitability and only a small LMND position on pullbacks. Lemonade’s profitability status and competition risk suggest a moderate potential impact on its trajectory, with investor sentiment sensitive but not decisively transformative.

3

Lemonade launches its Pet product in Kentucky, expanding Lemonade Pet to 44 states and DC and testing its app-first model. 1-day stock rise 2.1%, 30-day return -16.8%; 3-year total shareholder return about 2.9x signals longer-term momentum. Shares trade near $45 after a pullback, with revenue and net income growth still positive. Fair value pegged at $48.95, implying about 7.5% undervaluation. In-force premium rose 32.4% to $1.43B; revenue grew 79% as ceded premiums fell about 49% due to higher risk retention. Risks include a potential rise in gross loss ratio toward 70% or slower in-force growth. Some view the price as rich given a P/S of 3.6x vs peers around 1.8x. The piece suggests testing the thesis against other opportunities and notes sentiment risk. Kentucky expansion broadens reach and growth potential, but valuation and profitability risks temper upside.

22 Sep

4

Lemonade launches pet insurance in Kentucky, expanding Lemonade Pet Insurance to 44 states plus Washington, D.C. Pet parents can access accident and illness coverage, preventative care, and fast in-app claims. Customers can tailor annual deductibles, reimbursement rates, and policy limits, with optional add-ons such as vet visit fees, dental illness, physical therapy, behavioral conditions, and end-of-life expenses. Preventative care packages cover routine care for puppies and kittens. Multi-pet discounts apply for insuring multiple pets, and bundling with renters or homeowners discounts both policies. Quotes are available in minutes at lemonade.com/pet or via the Lemonade app. The company emphasizes a tech-driven, instant-claims experience and notes it now serves over 3 million customers in the US, UK and Europe, with many claims paid within seconds; Lemonade is a B-Corp with a Giveback program. Expands Lemonade's pet insurance footprint to Kentucky and enhances cross-sell with renters/home, potentially boosting premiums and customer retention.

18 Sep

3

Lemonade targets first EBITDA-positive quarter as CFO Tim Bixby transitions to board. CFO board transition paired with EBITDA target signals planned leadership continuity likely to moderately affect financial trajectory.

14 Sep

4

Lemonade CFO highlights opportunities in self-driving car insurance and cross-selling growth. CFO focus on self-driving insurance signals major strategic expansion into new market.

3

Lemonade improved its loss ratio to 60% and grew gross profit 76%, yet the stock remains 49% below its high. Better loss ratio and gross profit growth point to stronger core operations that can lift near-term financial results and sentiment.

4 Sep

3

Lemonade posted Q2 results in the property and casualty insurance sector with loss ratios, premium growth and competitive positioning detailed against sector peers. Q2 earnings data directly inform Lemonade's near-term financial trajectory and investor positioning.

3

Insurer halves rates per mile for Tesla autonomous driving, signaling shift toward usage-based coverage for self-driving vehicles with potential effects on Lemonade's positioning. Autonomous mileage discounts introduce competitive pressure in usage-based auto coverage that may affect Lemonade's innovation path.

2 Sep

3

Lemonade launches car insurance including autonomous vehicle coverage in Missouri. State expansion with autonomous car insurance adds moderate growth potential in a new product area.

26 Aug

3

Lemonade launches car insurance in Florida to expand U.S. operations. Florida car insurance launch adds one state and product line with moderate growth implications.

14 Aug

4

Lemonade halved its adjusted EBITDA loss to $19 million from $41 million and committed to achieving breakeven by Q4. Reduced losses and breakeven commitment signal credible path to profitability that can lift valuation and investor sentiment.

7 Aug

4 transcript

Lemonade (LMND) released its Q2 2026 earnings call transcript covering quarterly results, financial metrics, and management outlook on operations and growth. Earnings call details directly influence stock trajectory through performance data and forward guidance.

4 Aug

4

Lemonade stock plunged 26% in July after reporting weaker-than-expected results and reduced growth outlook. Sharp stock drop signals major challenges that will pressure future performance and investor sentiment.

3

Lemonade reported Q2 results with focus on whether investors should buy, sell or hold LMND stock based on financial performance and outlook. Q2 earnings directly shape near-term investor views on LMND financials and valuation.

3

Lemonade Inc (LMND) identified as growth stock with potential to 10X by 2034. LMND growth projection to 10X by 2034 may moderately influence company performance and investor views.

31 Jul

3

Lemonade's full-year in-force premium outlook misses expectations, raising questions on whether growth is slowing or merely repricing. Missed premium outlook directly signals weaker growth visibility and pressures near-term valuation.

30 Jul

3

Lemonade (LMND) stock drops sharply on weak performance signals and sector pressures. Stock nosedive reflects short-term operational and sentiment pressures without guaranteed long-term trajectory change.

3

Lemonade Inc. undergoes CFO transition, raising questions if it delays profitability or refines strategy. CFO transition may affect Lemonade's financial performance and profitability timeline.

29 Jul

4

Lemonade Inc posted record revenue in Q2 2026 alongside strategic AI initiatives during its earnings call. Record revenue and AI strategy signal major shifts in financial performance and competitive positioning.

4

Lemonade stock crashes today on weak results and heightened loss expectations that pressure near-term growth outlook. Sharp share-price drop reflects material negative shift in investor view of Lemonade's operating trajectory.

4 transcript

Lemonade Q2 earnings call highlighted premium growth, customer acquisition metrics, loss ratio trends and updated full-year guidance with focus on expense management and market expansion plans. Q2 earnings call delivered financial results, guidance and strategic updates with direct bearing on valuation and investor positioning.

4

Lemonade, Inc. (LMND) announced its second quarter 2026 financial results. Quarterly financial results typically drive significant shifts in stock valuation and investor outlook.

3

Lemonade (LMND) stock declines after issuing Q2 guidance, prompting questions on whether the company's valuation case holds. Q2 guidance triggers immediate stock drop with valuation sustainability now in question.

3

Lemonade reports Q2 earnings and reviews key metrics tied to its performance. Q2 earnings metrics directly affect views of financial results and near-term outlook.

3

Lemonade beat Q2 CY2026 sales expectations but its stock fell 15.1%. Sales beat offset by sharp stock drop points to investor doubts on outlook.

28 Jul

3

Lemonade (LMND) is scheduled to report earnings tomorrow, with investor expectations detailed for upcoming financial results and performance metrics. LMND earnings release tomorrow may moderately affect stock price and market sentiment through financial performance disclosure.

22 Jul

3

Lemonade (LMND) posts Q1 earnings, triggering buy, sell or hold assessments for investors. Q1 earnings results and stock recommendations may moderately influence near-term LMND investor sentiment and trading.

16 Jul

3

Lemonade retains a larger share of its insurance risk, raising questions on whether the move signals confidence in underwriting or flags potential concerns over future losses and capital needs. Shift in risk retention directly touches Lemonade's loss exposure, reinsurance costs, and investor views on capital management.

stockrow.com/LMND · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com